在急诊室发起的布普伦诺非因后的急性戒断:一项回顾性研究
Journal of addiction medicine
|December 19, 2025
概括
在急诊室布普伦诺芬启动后,在6.7%的患者中发生了急性戒断 (PW). 虽然这种情况并不常见,但这种情况强调了需要患者咨询和临床医生为管理PW做好准备.
科学领域:
- 紧急医疗 紧急医疗
- 成 药物 药物 药物 药物
- 药理学 药理学是指药理学的学科.
背景情况:
- 布普伦诺芬对于在急诊室治疗阿片类药物戒断至关重要.
- 临床医生和患者对急性戒断 (PW) 的担忧可能会限制布普伦诺芬的使用.
- 需要准确的PW发病率数据来指导ED治疗方案.
研究的目的:
- 准确估计在ED中布普伦诺芬开始后,急性戒断 (PW) 的发生率.
- 为了告知临床实践,并减少用于阿片类药物戒断的布普伦诺啡因使用障碍.
主要方法:
- 在15个马里兰大学医疗系统ED中接受ED启动布普伦诺芬的成年人的回顾性研究 (2019年1月 - 2023年12月).
- 排除标准包括延续已确定的治疗,住院订单,或缺少治疗前临床阿片类药物戒断量表 (COWS) 评分.
- PW被定义为在4小时内COWS增加≥5点或在第一剂布诺芬剂量后4小时内随着额外的阿片类药物给药而增加的COWS.
主要成果:
- 1229名患者接受了ED布普伦诺芬; 990人被排除在外,留下239名患者进行分析.
- 确定了16例急性戒断 (PW),导致6.7%的发病率 (95%CI:3.5%-9.9%).
- 在PW和初始COWS得分,布普伦诺芬配方,芬太尼使用或布普伦诺芬剂量之间没有发现显著的关联.
结论:
- 在这个队列中,急诊部发起的布普伦诺芬后的急性戒断 (PW) 不常见,但发生率高于之前的一些研究.
- 患者需要在布普伦诺芬治疗前就潜在的PW进行咨询.
- 临床医生必须准备好在出现PW症状时有效地管理PW症状.
相关概念视频
Desensitization and Tachyphylaxis
2.9K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.9K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
878
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
878
Drug Dependence
1.6K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.6K
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Depolarizing Blockers: Pharmocokinetics
553
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
553


